Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 细胞基因系统有限公司
- Publication Date
- 2007-11-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims the benefit of US Provisional Patent Application No. 60 / 604,009, filed August 25, 2004, which is incorporated herein by reference in its entirety. Technical field:
[0003] The present invention relates to adenoviral vectors comprising chimeric fibrin and exhibiting enhanced transduction of tumor cells, especially primary tumor cells, compared to non-chimeric adenoviral vectors. Background technique:
[0004] Gene therapy is used as a means of delivering exogenous nucleotide sequences to cells and is the basis for some of the most novel and promising disease-fighting tools. This approach is extremely useful in the treatment of not only cancer but many other diseases including cystic fibrosis, anemia, hemophilia, diabetes, Huntington's disease, AIDS, abnormally high serum cholesterol, certain immunodeficiencies, and many forms of cancer. big prospects. Gene therapy typically relies on delivery ...